Evidence map›Paper›PMID 28153336›Full record

ArticleBiological psychiatry2017

Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder.

Yanni Zeng, Pau Navarro, Masoud Shirali, David M Howard, Mark J Adams, Lynsey S Hall, Toni-Kim Clarke, Pippa A Thomson, Blair H Smith, Alison Murray and 30 more

Open access · hybridAbstract read
In one paragraph

Article in Biological psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Pooled it
  3. Article
  4. Review
  5. The long noncoding RNAbioRxiv : the preprint server for biology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. ElevatedProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 17 institutions in 7 countries.

Yanni ZengDivision of Psychiatry, University of Edinburgh, Edinburgh. Electronic address: y.zeng-6@sms.ed.ac.uk.
Pau NavarroMedical Research Council Human Genetics Unit, University of Edinburgh, Edinburgh.
Masoud ShiraliMedical Research Council Human Genetics Unit, University of Edinburgh, Edinburgh; Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh.
David M HowardDivision of Psychiatry, University of Edinburgh, Edinburgh.
Mark J AdamsDivision of Psychiatry, University of Edinburgh, Edinburgh.
Lynsey S HallDivision of Psychiatry, University of Edinburgh, Edinburgh.
Toni-Kim ClarkeDivision of Psychiatry, University of Edinburgh, Edinburgh.
Pippa A ThomsonCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh.
Blair H SmithDepartment of Psychology, University of Edinburgh, Edinburgh; Division of Population Health Sciences, University of Dundee, Dundee.
Alison MurrayDivision of Applied Health Sciences, University of Aberdeen, Aberdeen.
Sandosh PadmanabhanCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow.
Caroline HaywardCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh.
Thibaud BoutinCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh.
Donald J MacIntyreDivision of Psychiatry, University of Edinburgh, Edinburgh.
Cathryn M LewisMRC Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
Naomi R WrayQueensland Brain Institute, University of Queensland, St. Lucia, Queensland.
Divya MehtaQueensland Brain Institute, University of Queensland, St. Lucia, Queensland.
Brenda W J H PenninxDepartment of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
Yuri MilaneschiDepartment of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
Bernhard T BauneDiscipline of Psychiatry, University of Adelaide, Adelaide, Australia.
Tracy AirDiscipline of Psychiatry, University of Adelaide, Adelaide, Australia.
Jouke-Jan HottengaDepartment of Biological Psychology, VU University, Amsterdam, The Netherlands.
Hamdi MbarekDepartment of Biological Psychology, VU University, Amsterdam, The Netherlands.
Enrique CastelaoDepartment of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.
Giorgio PistisDepartment of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.
Thomas G SchulzeInstitute of Psychiatric Phenomics and Genomics, Ludwig-Maximilians-University, Munich Cluster for Systems Neurology, Munich; Department of Psychiatry and Psychotherapy, University Medical Center, Georg-August-University, Göttingen; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg.
Fabian StreitDepartment of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim.
Andreas J ForstnerInstitute of Human Genetics, Life and Brain Center, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
Enda M ByrneQueensland Brain Institute, University of Queensland, St. Lucia, Queensland.
Nicholas G MartinSchool of Psychology, University of Queensland, St. Lucia, Queensland.
Gerome BreenMRC Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
Bertram Müller-MyhsokMax Planck Institute of Psychiatry, Munich Cluster for Systems Neurology, Munich.
Susanne LucaeMax Planck Institute of Psychiatry, Munich Cluster for Systems Neurology, Munich.
Stefan KloiberMax Planck Institute of Psychiatry, Munich Cluster for Systems Neurology, Munich.
Enrico DomeniciLaboratory of Neurogenomic Biomarkers, Centre for Integrative Biology, University of Trento, Trento, Italy.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Ian J DearyGeneration Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh; Department of Psychology, University of Edinburgh, Edinburgh.
David J PorteousCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh; Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh.
Chris S HaleyMedical Research Council Human Genetics Unit, University of Edinburgh, Edinburgh; The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Edinburgh.
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh; Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh.
University of Edinburgh · GBEdinburgh Cancer Research · GBThe University of Queensland · AUMunich Cluster for Systems Neurology · DEAmsterdam UMC Location Vrije Universiteit Amsterdam · NLHeidelberg University · DEKing's College London · GBThe University of Adelaide · AUUniversity of Lausanne · CHAlzheimer Scotland · GBMedical Research Council · GBRoslin Institute · GBUniversity of Aberdeen · GBUniversity of Bonn · DEUniversity of Dundee · GBUniversity of Glasgow · GBUniversity of Trento · IT

Funding

Biotechnology and Biological Sciences Research Council BB/F019394/1Biotechnology and Biological Sciences Research Council BB/J002844/1Biotechnology and Biological Sciences Research Council BBS/E/D/20211553Chief Scientist Office CZD/16/6Medical Research Council MC_PC_U127561128Medical Research Council MC_PC_U127592696Medical Research Council MC_QA137853Medical Research Council MC_U127592696Medical Research Council MR/K026992/1Wellcome Trust 104036
6 · The paper itself

Abstract

backgroundMajor depressive disorder (MDD) is the second largest cause of global disease burden. It has an estimated heritability of 37%, but published genome-wide association studies have so far identified few risk loci. Haplotype-block-based regional heritability mapping (HRHM) estimates the localized genetic variance explained by common variants within haplotype blocks, integrating the effects of multiple variants, and may be more powerful for identifying MDD-associated genomic regions.

methodsWe applied HRHM to Generation Scotland: The Scottish Family Health Study, a large family- and population-based Scottish cohort (N = 19,896). Single-single nucleotide polymorphism (SNP) and haplotype-based association tests were used to localize the association signal within the regions identified by HRHM. Functional prediction was used to investigate the effect of MDD-associated SNPs within the regions.

resultsA haplotype block across a 24-kb region within the TOX2 gene reached genome-wide significance in HRHM. Single-SNP- and haplotype-based association tests demonstrated that five of nine genotyped SNPs and two haplotypes within this block were significantly associated with MDD. The expression of TOX2 and a brain-specific long noncoding RNA RP1-269M15.3 in frontal cortex and nucleus accumbens basal ganglia, respectively, were significantly regulated by MDD-associated SNPs within this region. Both the regional heritability and single-SNP associations within this block were replicated in the UK-Ireland group of the most recent release of the Psychiatric Genomics Consortium (PGC), the PGC2-MDD (Major Depression Dataset). The SNP association was also replicated in a depressive symptom sample that shares some individuals with the PGC2-MDD.

conclusionsThis study highlights the value of HRHM for MDD and provides an important target within TOX2 for further functional studies.

Indexed as

Genetic Predisposition to DiseaseHaplotypesPolymorphism, Single NucleotideCohort StudiesFemaleGenetic LociGenome-Wide Association StudyHMGB ProteinsHumansIrelandMajor Depressive DisorderMaleMiddle AgedUnited KingdomHMGB ProteinsTox2 protein, humanGenome-wide analysesHaplotype blockHRHMMDDRegional heritabilityTOX2

Identifiers

PMID28153336
PMCPMC5553996
OpenAlexW2565752667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.